Usage of indocyanine green in routine practice in surgical oncology
Summary. Indocyanine green (ICG) is known for its ability to stain tissues in fluorescent manner and has become the subject of increasing interest in the field of surgical oncology. It is used to improve the detection rate of the particular anatomical structures and the precise localization of tumors. ICG represents a promising strategy that allows surgeons to delineate and precisely remove malignant tumors reducing the risk of healthy tissues damage and improve oncological outcomes. The aim of this study is literature review and analysis of the indications and limitations of the use of ICG in the treatment of oncogynecological pathology as well as malignant neoplasms of the stomach and esophagus. The review assesses data on the potential impact of ICG on improving results of diagnostic manipulations and surgical interventions in malignant diseases. Based on the literature review it was established that the use of ICG in surgical oncology improves visualization of anatomical structures during surgical interventions. Its use is safe for patients, although it may be accompanied by some side effects. Conclusions. The injection of ICG prior to surgical interventions helps to improve oncological outcomes and does not affect postoperative complications and mortality rate. However, additional prospective studies are needed to determine optimal usage regimens and to maximize patient benefit and safety.
Leave a comment